InSnip Pure Signal, No Noise
✓ Source-backedMoney & Work
Federal tax cut will cost Newcastle biotech ImmVirX $6m annually
Newcastle biotech ImmVirX will lose $6.3 million a year under planned federal cuts to research tax breaks.
Why it mattersBiotech drug development takes over a decade. Cutting tax support to young companies risks slowing cancer research. It could push investment overseas instead.
Free. Be genuinely informed in 5 minutes a day. No signup, no noise.
Get the free app, read the whole feed
InSnip turns the day's news into short, source-backed snippets with a plain why it matters line. The signal, not the scroll.